Did you know that there are currently 38 clinical studies and researches being carried out at Pantai Hospital Kuala Lumpur to improve quality of care and clinical outcomes? These are driven by none other than Malaysia Operation’s first Research & Innovation Department set up in November last year.
Senior Research Scientist Dr Wong Shin Yee, a PhD holder in Molecular Medicine, heads the new department, supported by a team of experienced study coordinators and research assistants. For months now, they have been working with different stakeholders on the 38 approved studies that span multiple medical fields.
Cancer therapy is the current research focus, with 14 oncology clinical trials underway relating to breast cancer and non-small cell lung carcinoma. In addition, there are five oncology studies initiated by the consultants at Pantai Hospital Kuala Lumpur to determine the clinical outcomes of cancer patients at Pantai Hospital Kuala Lumpur.
The team is making good headway and looks forward to share their research outcomes soon. Stay tuned.
Related Stories
IHH Laboratories D.N.A. Award
Discovery. Nurturing. Accuracy. The IHH Labs D.N.A. Award returns in 2026 to recognise medical technologists whose work forms a vital part of quality patient care.
.jpg?sfvrsn=21d67f46_1)
IHH Singapore Collaborates with Insurers to Improve Affordability of Private Hospital Care
Taking Preventive Health to New Heights at The IHH Sky Race | Merdeka 118
IHH Healthcare Malaysia highlights Care. For Good. through its role as title partner and official medical provider of The IHH Sky Race | Merdeka
People-led Innovation Driving Impact Across IHH Healthcare
Gleneagles Hospital Hong Kong Highlights Healthcare at ITB China 2026
Travel today is no longer defined by destinations alone — it is shaped by the confidence and assurance travellers carry with them.
IHH Malaysia Strengthens Care Integration Through GP-Specialist Collaboration
A referral is more than an appointment with another doctor, it is an act of trust.
